The role of stem cell transplantation in
β
Jean-Luc Harousseau; Michel Attal
π
Article
π
2002
π
Elsevier Science
π
English
β 193 KB
High-dose therapy with autologous stem cell transplantation (ASCT) has been extensively used in the past 15 years in multiple myeloma. The IFM 90 trial has shown that autologous bone marrow transplantation (BMT) is superior to conventional chemotherapy in terms of response rate, event free survival,